CDC

Dear Research Advocate, Fourth of July, typically a day to unwind and celebrate, comes to us this year at a fraught time in our fight against a deadly pandemic. Evidence-based public health practices to mitigate the virus’s spread have been too often politicized and unheeded, leading to adherence gaps by some that place many others at risk. Cautious optimism from public health experts that we were on a path to containing the virus is being overtaken by alarm. Public health officials in communities across the country are being physically threatened while laboring under poorly-resourced conditions. An important time to hear from Dr. Tom Frieden, former CDC Director and current President and...
Dear Research Advocate, This past Monday, CDC Director Dr. Robert Redfield was our guest for the first of two alliance member calls this week, stressing the roles we all have to play: “I think this is an all-of-the nation response, not just an all-government response…. There’s no doubt we're going to learn a lot of lessons. But, I am 100 percent confident when we get to the other side, we're going to be so much stronger.” We are grateful to Director Redfield for spending time with us. Read more here . Innovation is key : Dr. Redfield repeatedly called for innovation: “I look forward to the innovation that we’re going to see from many of [Research!America’s] members to improve the tools we...
Research!America hosted an alliance member call for members and partners on April 13, 2020 with Dr. Robert Redfield, Director, Centers for Disease Control and Prevention. Dr. Redfield opened with an overview of the COVID-19 pandemic and the CDC’s response. He stressed that COVID-19 is the greatest public health challenge the United States has faced in over a century and highlighted the CDC’s deployment of personnel, development and expansion of serology testing, and distribution of funding to state, local, and tribal public health departments. He also emphasized that our nation should use this time to expand the existing public health infrastructure in order to be better prepared for future...
Dear Research Advocate, Because Research!America’s membership spans the ecosystem of stakeholders in research, we are fortunate to have access to a broad and comprehensive range of information you might find helpful. Visit and share our COVID-19 webpage. www.ResearchAmerica.org/COVID19 . A CDC report just out indicates that younger Americans have been hospitalized with COVID-19 at a higher rate than anticipated. As we look ahead to the use of vaccines against this and other threats, we have new (in the field just last evening) survey data showing that almost two-thirds of Americans ages 18-29 may not fully understand the role of vaccines. Better news is that this demographic is increasingly...
Dear Research Advocate, In their different ways, Super Tuesday and COVID-19 both speak to public sentiment. What are Americans’ expectations for those who represent them in Washington — and candidates who want to represent them in Washington — when it comes to promoting and protecting their best interests? A new Research!America-commissioned survey (in the field just days before COVID-19 captured worldwide public attention) found that Americans want their policymakers to consult with public health professionals and scientists; are deeply concerned about a diversity of public health issues affecting their families, their communities, and our nation as a whole; and believe there should be...
Dear Research Advocate, There’s a lot going on right now, so this letter is a bit longer than usual. Stay with me! Let’s start with the Super Bowl. According to the National Retail Federation, this year’s Super Bowl-related spending is on track to be the highest ever: $17.2 billion. That’s enough to fund: NIH-sponsored research on chronic pain for more than 26 years. CDC’s National Center for Injury and Prevention Control for almost 27 years. The entire Agency for Healthcare Research and Quality budget , which plays a profoundly underappreciated role in driving better health and healthcare, for more than 38 years. This is a wealthy country; we don’t need to stop spending on all things Super...
Dear Research Advocate, This week’s headlines about the coronavirus certainly underscore how nimble and prepared our federal research agencies must always be. It’s a compelling reason health research agencies must be well-funded and well-coordinated. The CDC, FDA, and NIH trifecta are on high alert, playing leading roles in global efforts to identify and contain the deadly virus. After Chinese researchers sequenced the virus’ genome, they posted it in GenBank, a database managed by NIH. The CDC has submitted a diagnostic test to the FDA for use in select public health labs around the country. NIH is working with industry on a vaccine they hope to have ready for human trials in a few months...
Dear Research Advocate: As 2020 begins, you no doubt have made personal and professional resolutions. How could you not? With information concerning exercise , diet , and smoking cessation flooding our screens, one feels almost left out if not pledging improvement. (The links above are to evidence-based sources only; not current reality, but hope springs eternal). Here are a few advocacy resolutions to consider: Resolution1: Celebrate your successes! Members of the Research!America Alliance have much to be proud of and grateful for as we look back at 2019. Individually and collectively, day in and day out, we spoke out: we made the case for raising the budget caps, boosting science funding...
Did you know that in the United States alone someone gets an antibiotic-resistant infection every 11 seconds, and every 15 minutes someone dies as a result? That means people are dying of infections that are no longer responding to the drugs designed to kill them. This new data comes from CDC’s recently released Antibiotic Resistance Threats in the United States, 2019 showing that antibiotic-resistant pathogens are causing more than 2.8 million infections and 35,000 deaths across the U.S. As the report shows, too many people are still affected by resistant infections, many of which are preventable. The world can do more to prevent these infections and to stop the spread of pathogens across...
Dear Research Advocate, With new rumors surfacing daily, it’s difficult to gauge the odds of Congress and the Trump Administration completing FY20 appropriations this calendar year. We are now anticipating another short-term CR that will flat-fund government into December, buying a bit more time for final negotiations. If those negotiations fail, the options become yet another CR or a government shutdown. None of these scenarios serves the public interest. Imagine if federal agencies couldn’t adjust spending to jettison what is not working and invest in what is. Imagine if there were resources to seed the kind of medical and public health progress that saves lives, yet those resources lie...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln